tutorial arrow
×
Create your own tool library
Bookmark tools and put favorites into folders to find them easily.

LigQ

Online

Aids the researcher in the selection and preparation of ligands-as well as the desired protein receptor-for a Virtual Screening (VS) procedure. The LigQ web based tool is divided in four semi-independent modules that allow user to determine: 1) the receptor ligand binding pocket, 2) the known ligands for the desired protein and family members, 3) a set of purchasable ligands enriched in potential binders, and 4) 3D structures for selected ligands ready for the VS.

User report

tutorial arrow
×
Vote up tools and offer feedback
Give value to tools and make your expertise visible

0 user reviews

0 user reviews

No review has been posted.

LigQ forum

tutorial arrow
×
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.

No open topic.

LigQ classification

LigQ specifications

Restrictions to use:
None
Input format:
PDB, UniProt
Stability:
Stable
Input data:
a target ID.
Computer skills:
Basic
Maintained:
Yes

LigQ support

Maintainer

  • Marcelo Martí <>

Credits

tutorial arrow
×
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.

Publications

Institution(s)

Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina; Insituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICENCONICET), Buenos Aires, Argentina; Department of Physical Chemistry, Faculty of Pharmacy and Institute of Biomedicine (IBUB), University of Barcelona, Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain

Funding source(s)

Supported by grants PICT-GSK-2012-057 and PIP1220110100850, PICT-2010-2805, the Spanish Ministerio de Economía (SAF2012-33481), and the Catalan government (2014 SGR 1189).

Link to literature

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.